财报数据
| EPS 实际 | $2.5 |
| EPS 预期 | $2.1409 |
| EPS 超预期 % | +16.77% |
| 收入实际 | $2,770,800,000 |
| 收入预期 | $2,667,167,614 |
| 判据命中 | 数值 A 新闻 B |
观察状态
| 状态 | 🟢 已收尾 |
| Time0（观察起点） | 2026-04-22 12:00:00 UTC （盘前） |
| 基准价 P₀ | $460.54 |
| 累计最高价 | $463.00 |
| 峰值涨幅 | +0.53% |
| Time1（回撤触发） | 2026-04-22 12:28:00 UTC |
| Time1 价格 | $457.39 |
| 最终涨幅 | -0.68% |
分钟级价格（Massive 数据） 绿线 = Time0 发生时刻 · 红线 = Time1 回撤触发时刻
加载中…
触发新闻（1 条）
按发布时间升序；最早一篇的 published_utc 即为 Time0
2026-04-22 11:57:29 UTC
· Benzinga
·
✓ LLM 判定为 beat
（置信 0.99）
Intuitive Surgical reported strong Q1 2026 results, beating revenue and EPS estimates at $2.77B and $2.50 per share respectively. The company raised its 2026 Da Vinci procedure growth guidance to 13.5…
└ LLM 理由: The article says Intuitive Surgical reported Q1 2026 results that beat both revenue estimates ($2.77B) and EPS estimates ($2.50 per share), which is a clear just-reported earnings beat.